ICD-10 Coding for Klebsiella oxytoca Infection(A41.5, A41.5U, A41.89)
Learn about ICD-10 coding for Klebsiella oxytoca infections, including primary and ancillary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Klebsiella oxytoca Infection
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| A41.89 | Other specified sepsis | Use when Klebsiella oxytoca is confirmed as the causative organism in sepsis. |
|
| B96.89 | Other specified bacterial agents as the cause of diseases classified elsewhere | Use as an additional code to specify Klebsiella oxytoca as the infectious agent. |
|
| Z16.1 | Resistance to other beta-lactam antibiotics | Use when Klebsiella oxytoca is confirmed to be ESBL-producing. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutKlebsiella oxytoca Infection
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Klebsiella oxytoca Infection.
Failing to document antibiotic resistance.
Impact
Clinical: Inadequate treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement for resistant infections.
Mitigation
Review lab reports for resistance data., Document resistance in clinical notes.
Using A41.5 for Klebsiella oxytoca infections.
Impact
Reimbursement: Incorrect coding may lead to improper DRG assignment., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation
Use A41.89 and B96.89 to correctly code Klebsiella oxytoca.
Organism Specification
Impact
Risk of audits due to unspecified organism in sepsis coding.
Mitigation
Ensure all sepsis cases specify the causative organism.